Allelic frequency of PCR-RFLP type of the BoLA-DRB3 in Japanese Holstein herds and the relation to mastitis

Holstein Cows ( n  = 702) from 26 dairy herds in the Tama area of Tokyo, Japan were examined for polymorphisms of the BoLA-DRB3 allele using a PCR-RFLP method. Twenty alleles were observed and allelic frequencies ranged from < 1% to 20.3%. Nine alleles ( DRB3.2 * 24, * 16, * 8, * 23, * 22, * 3, * 11 , * 10 and * 7 in order) constituted 90.0% of all alleles. Somatic cell counts (SCC) were used to classify healthy (group 1), mastitis (group 2) and suspected (group 3) cows. Frequencies of DRB3.2 * 11 and DRB3.2 * 23 were slightly higher in group 1 than in group 2, whereas, frequencies of DRB3.2 * 8 and DRB3.2 * 16 were slightly higher in group 2 than in group 1. However, none of the differences in frequencies between the two groups were statistically significant. For combinations of alleles, frequencies of DRB3.2 * 8/ * 23 ( P  < 0.1) and DRB3.2 * 16/ * 24 ( P  < 0.05) were significantly higher in group 2 than in group 1, and their odds ratios were 2.1, 2.5, respectively. However, there were no significant differences between genotypes in their effects for SCC. On the other hand, frequency of DRB3.2 * 23/ * 23 including combinations of DRB3.2 * 23 with minor alleles was significantly higher in group 1 than in group 2 ( P  < 0.01), and the odds ratio was 0.3. Therefore, it was considered that mastitis resistance or susceptibility of cows may vary with the combination of BoLA-DRB3 alleles.     

Association of BoLA-DRB3 alleles identified by a sequence-based typing method with mastitis pathogens in Japanese Holstein cows

The association of the polymorphism of bovine leukocyte antigen ( BoLA-DRB3 ) genes identified by the polymerase chain reaction sequence-based typing (PCR-SBT) method with resistance and susceptibility to mastitis caused by pathogenic bacteria was investigated. Blood samples for DNA extraction were collected from 194 Holstein cows (41 healthy cows and 153 mastitis cows including 24 mixed-infection cows infected with 2 or 3 species of pathogens) from 5 districts of Chiba prefecture, Japan. Sixteen BoLA-DRB3 alleles were detected. The 4 main alleles of DRB3*0101 , *1501 , *1201 , and *1101 constituted 56.8% of the total number of alleles detected. Mastitis cows were divided into 2 groups: group 1 with single-infection cows and group 2 with all mastitis cows including 24 mixed-infection cows. The differences in the frequencies of BoLA-DRB3 alleles and the number of cows homozygous or heterozygous for each BoLA-DRB3 allele between healthy cows and the 2 groups of mastitis cows were evaluated. Furthermore, similar comparisons were performed between healthy cows and the 2 groups of mastitis cows for each mastitis pathogen. It was considered that the 4 alleles, namely, DRB3*0101 , *1501 , *1201 , and *1101 had specific resistance and susceptibility to 4 different mastitis pathogens. Thus, DRB3*0101 might be associated with susceptibility to coagulase-negative Staphylococci and Escherichia coli , and DRB3*1501 might be associated with susceptibility to Escherichia coli . However, DRB3*1101 might be associated with resistance to Streptococci and coagulase-negative Staphylococci , and DRB3*1201 , with resistance to Streptococci , Escherichia coli , and Staphylococcus aureus .     

Presence of glutamine at position 74 of pocket 4 in the BoLA-DR antigen binding groove is associated with occurrence of clinical mastitis caused by Staphylococcus species

Potential relationships between amino acid motifs in the antigen binding groove of various alleles of the bovine major histocompatibility complex DR (BoLA-DR) molecule and occurrence of clinical mastitis caused by Staphylococcus species (non-Staphylococcus aureus) were investigated in a case-control study. A significant association (P< or =0.05) was detected between the presence of glutamic acid at position beta 74 and occurrence of mastitis caused by Staphylococcus spp. with a relative risk of 11. This motif is present in BoLA-DRB3.2*22, *23 and *24 alleles. Presence of a positively charged residue (arginine or lysine) at position 13 also showed a tendency (P< o r=0.1) towards an association with a higher risk of clinical mastitis caused by the same bacteria. This motif is present in BoLA-DRB3.2*23 and *8 alleles. Similarly, presence of arginine at position beta 71 (present in alleles *23 and *22) was associated with occurrence of this disease. These positions (beta 13, beta 71 and beta 74) form pocket 4 of the antigen binding groove, which plays an instrumental role in antigen binding and recognition by T-lymphocytes. Thus, it can be concluded that pocket 4 of the BoLA-DR molecule is involved in conferring susceptibility to clinical mastitis caused by Staphylococcus spp.     

Detection of bovine leukocyte antigen DRB3 alleles as candidate markers for clinical mastitis resistance in Holstein x Zebu

Bovine leukocyte antigen DRB3 alleles from Holstein x Zebu crossbred dairy cows (n = 409) were analyzed using the PCR-RFLP technique. Exon II of DRB3 was amplified using locus-specific primers (HLO30/HLO32), followed by digestion with 3 restriction enzymes (RsaI, BstyI, and HaeIII). Forty alleles were found with frequency ranging from 0.005 to 0.139. The most frequently detected alleles of Holstein x Zebu were DRB3*16, *51, *23, *11, *8, and *1, accounting for 61.12% of the alleles in the population. Detection of candidate alleles for clinical mastitis occurrence was performed by logistic regression. It was found that percentage of Holstein fraction in crossbred cows had a nonsignificant effect (P > 0.05). However, parity had a significant effect on mastitis occurrence. In addition, DRB3*1 and *52 were the most associated with the occurrence of clinical mastitis, whereas *15, *51, and *22 were associated with resistance in crossbred populations. This is the first report of association of DRB3*15 and *51 with mastitis resistance. The association was validated by examining the candidate alleles in another commercial population. Highly susceptible (n = 43) and resistant (n = 42) groups of Holstein x Zebu cows were investigated. The result confirmed that DRB3*1 and *52 could be considered as susceptibility alleles, whereas *15, *51, and *22 could be considered as resistant alleles in Holstein x Zebu raised under tropical conditions. In addition, allele effects on 305-d milk production were estimated by BLUP. It was shown that most alleles associated with high clinical mastitis occurrence were related to increased milk yield. This study revealed that allele DRB3*10 had the greatest effect on increasing milk yield with moderate resistance to clinical mastitis, which could be used as a potential marker for selection in dairy genetic evaluation.     

Analysis of Relationship between Bovine Lymphocyte Antigen DRB3.2 Alleles, Somatic Cell Count and milk Traits in Iranian Holstein Population

The major histocompatibility complex (MHC) is a gene complex closely linked to the vertebrate immune system due to its importance in antigen recognition and immune response to pathogens. To improve our understanding of the MHC and disease resistance in dairy cattle, we gathered 5119 test day records of somatic cell count (SCC) and performance traits of 262 Holstein dairy cows to determine whether the DRB region of the MHC contains alleles that are associated with elevated SCC, milk yield, protein and fat percent of milk. To this purpose, genotyping of animals for DRB3 gene was investigated by polymerase chain reaction‐based restriction fragment length polymorphism (PCR‐RFLP) assay. A two‐step PCR was carried out so as to amplify a 284 base‐pair fragment of exon 2 of the target gene. Second PCR products were treated with three restriction endonuclease enzymes RsaI, BstYI and HaeIII. Twenty‐eight BoLA‐DRB3 alleles were identified including one novel allele (*40). The results in general are in good accordance with allele frequencies of Holstein cattle populations reported by previous studies. Analyses of associations were modeled based on repeated measurement anova and generalized logistic linear methods for production traits and SCC data, respectively. The results of this study showed a significant relationship between the elevated SCC reflecting an increased probability of occurrence to subclinical mastitis and DRB3.2 allele *8 (p < 0.03). The results also revealed significant positive relationships of alleles*22 (p < 0.01) and allele*11 (p < 0.05) with milk fat percent as well as of alleles*24 (p < 0.03) and *22 (p < 0.05) with protein percent. The present study failed to find any association between milk yield and tested alleles. Because of the lack of consistency among results of similar studies, we suggest further investigations to determine the precise nature of these associations with the high polymorphic bovine MHC region to be performed based on haplotypes.     

Association of BoLA‐DRB3 alleles with mastitis resistance and susceptibility in Japanese Holstein cows

In this study, 714 cows from 26 dairy herds were reclassified as healthy or mastitic cows on the basis of long‐term somatic cell count (SCC) in milk. Cows with more than three consecutive lactation records of SCC from the first or second to fifth lactation, were selected, and their BoLA‐DRB3 (DRB3) alleles were identified using polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) method. Cows with an SCC of < 200 000 cells/mL in all monthly records were classified as healthy (n = 91). Cows with an SCC of > 300 000 cells/mL in two consecutive tests or four non‐consecutive tests or cows with an SCC of > 500 000 cells/mL in any one test during lactation, regardless of parity, were classified as mastitic (n = 201). Mastitic cows (n = 153) from another 40 herds were considered to be infected if bacteriological testing revealed mastitis pathogens in milk. Their DRB3 alleles were identified using PCR‐sequence‐based typing (PCR‐SBT). The differences in DRB3 allelic frequencies between healthy cows and cows with various degrees of mastitis were re‐investigated. Moreover, the associations of various amino acid motifs in DRB3 alleles with resistance or susceptibility to mastitis pathogens were re‐examined. DRB3.2*8(DRB3*1201) and DRB3.2*16(DRB3*1501) alleles were found to be associated with susceptibility, while DRB3.2*22(DRB3*1101), DRB3.2*23(DRB3*2703), and DRB3.2*24(DRB3*0101) alleles were found to be associated with resistance.     

Association of the amino acid motifs of BoLA-DRB3 alleles with mastitis pathogens in Japanese Holstein cows

The association of the polymorphism of bovine leukocyte antigen ( BoLA-DRB3 ) genes, identified by the polymerase chain reaction sequence-based typing (PCR-SBT) method, with resistance and susceptibility to mastitis caused by Streptococci , coagulase-negative Staphylococci, Escherichia coli and Staphylococcus aureus was investigated. Blood samples for DNA extraction were collected from 170 Holstein cows (129 mastitis and 41 healthy cows) from 5 districts in Chiba prefecture, Japan. Susceptibility or resistance to the mastitis-causing pathogens was thought to vary by the presence of amino acid substitutions at the 9, 11, 13, and 30 positions. DRB3*0101 and DRB3*1501 had amino acid motifs of Glu⁹, Ser¹¹, Ser¹³, and Tyr³⁰, and they were considered to have susceptibility to all 4 mastitis pathogens. In contrast, DRB3*1101 and DRB3*1401 had amino acid motifs of Gln⁹, His¹¹, Gly¹³, and His³⁰ in these positions, and they also had Val⁸⁶, so these alleles were considered to have resistance to Streptococcal and coagulase-negative Staphylococcal mastitis. However, in the case of Escherichia coli mastitis, amino acid substitutions at the 9, 11, 13, and 30 positions had little effect, but rather substitutions at the 47, 67 positions of pocket 7, and at the 71, 74 positions of pocket 4, Tyr⁴⁷, Ile⁶⁷, Ala⁷¹, and Ala⁷⁴, were associated with resistance. This motif was present in DRB3*1201 .     

Association of class I bovine lymphocyte antigen complex alleles with in vitro blood neutrophil functions, lymphocyte blastogenesis, serum complement and conglutinin levels in dairy cattle

Ninety-eight lactating Holstein cows from two genetic lines selected for high and average milk production were used in the study. Five peripheral blood samples were collected over a 60-day period from each cow for evaluation of neutrophil function, lymphocyte blastogenesis, leukocyte count, and serum complement and conglutinin levels. Blood samples were typed for antigens encoded by alleles at the bovine major histocompatibility complex (BoLA) A locus. Alleles w14(w8), w20A, and w19(w6) were the most frequent of 14 alleles present in this herd. Association of BoLA type with immune function results was examined by using gene substitution models including and ignoring sire effects. Alleles w15(w8) and w16 were associated with greater circulating mononuclear cell and total leukocyte numbers, while w27(w10), w11, and w20A were associated with lower numbers of these cell types. Alleles EU28D and w20A were positively and negatively associated with granulocyte percentage, respectively. Allele w16 was associated with greater antibody-independent neutrophil cytotoxicity, unstimulated lymphocyte proliferation, serum conglutinin activity, and with lower antibody-dependent neutrophil cytotoxicity. Allele w19(w6) was associated with decreased conglutinin activity and decreased neutrophil iodination. Increased antibody-dependent neutrophil cytotoxicity was observed for animals bearing allele w14(w8), and decreased neutrophil iodination, serum conglutinin, and nonstimulated lymphocyte blastogenesis were observed in individuals carrying w20A or EU28D. Significance of both sire and BoLA complex effects suggests that both major histocompatibility complex genes and background genes of the sire significantly affect immune function. This research suggests BoLA-A locus genes may be major genes or markers for closely linked major genes involved in regulation of nonspecific immune function.     

中药复方治疗奶牛乳腺炎临床试验

从822头奶牛中筛选出65例临床型乳腺炎患牛进行试验,探讨中药对奶牛乳腺炎的治疗作用。将患牛随机分为2组,试验组奶牛用中药复方治疗,对照组用青霉素和链霉素治疗,观察临床效果。结果中药复方治疗患牛33例,治愈26例,治愈率为78.8%;对照组治疗32例,治愈27例,治愈率为84.3%。经统计学处理,用中药复方治疗奶牛乳房炎与常用抗生素的治疗效果基本相同,但成本较低、副作用较小。     

An epidemiological and genetic study on registered diseases in Finnish Ayrshire cattle. IV. Clinical mastitis

The epidemiology and genetic variability of clinical mastitis were examined. The data consisted of 70,775 Finnish Ayrshire cows. All cows were from milk recorded herds and calved during 1983. Each cow was under observation from the date of calving for 305 days. Only clinical mastitis diagnosed and treated by a veterinarian during the farm visits were taken into account. The lactation incidence rate of clinical mastitis (LIR) was 5.4 %. The cows calving in April-May had the highest LIR, but the seasonal variation was relatively small. The LIR increased with parity from the first to sixth parity. The cows treated for parturient paresis, infertility or ketosis had a higher risk of clinical mastitis than cows not treated for these diseases. The LIR was higher in herds with a high milk production level. The highest odds ratio estimated from parameters of the logit model was 14.8. The heritability estimates for clinical mastitis on the binomial scale were 3.2 % in parity 1, 1.6 % in parity 2, 0.6 % in parity 3 and 4, and 0.8 % in all parities (corresponding to 19.7 %, 8.3 %, 2.6 % and 3.8 % on the normal scale). These estimates indicate sufficient assurance for progeny testing of bulls and some possibilities of genetic selection against clinical mastitis. Genetic correlations between clinical mastitis and 305-days milk yield were 0.39 in parity 1, 0.51 in parity 2, 0.18 in parity 3–4 and 0.58 in all parities. This means that the best sires for milk yield had daughters with a higher LIR for clinical mastitis than the other sires.     

中国南方地区荷斯坦奶牛BoLA-DRB3.2的RFLP分析

用PCR-RFLP方法检测中国南方地区奶牛BoLA-DRB3.2的RFLP多态性。选用RsaI、HaeIII和Bst YI酶切PCR扩增产物,14%PAGE分离酶切片段。HaeIII位点检测到6种等位基因,RsaI位点检测到11种等位基因,而在BstYI位点仅检测到4种等位基因。结果表明BoLA-DRB3.2的多态性极其丰富。PCR-RFLP是BoLA-DRB3分型的一种快速而有效的方法。     

生物氧疗法在治疗奶牛临床型乳房炎上的应用

本试验采用生物氧(成分为臭氧)结合抗生素治疗奶牛临床型乳房炎,并对生物氧疗法的疗效进行评价。2009年9月份~11月份,选取患有临床型乳房炎的奶牛30头并随机分为两组,每组15头。试验组采用生物氧结合抗生素疗法,对照组只采用抗生素疗法。结果发现,试验组平均治愈时间为7.4d,治愈14头,治愈率为93.33%,而对照组平均治愈时间为12.6d,治愈11头,治愈率为73.33%。从试验结果可以发现生物氧疗法在治疗奶牛临床型乳房炎上效果显著,有良好的应用前景。     

Impact of Mastitis Control Measures on Milk Production and Mastitis Indicators in Smallholder Dairy Farms in Kiambu District,Kenya

Bovine mastitis and mastitis control were investigated on smallholder farms in central Kenya. After an initial observational study, a clinical trial to assess the impact of three different mastitis control strategies – (1) improved udder hygiene, (2) treatment of subclinical cases, and (3) a combination of these – was conducted on 100 randomly selected farms with 332 lactating cows. Before the implementation of control measures, the milk yield was low (mean 6.5 kg/day; median 6 kg/day) and somatic cell counts (SCC) were high, with 80% and 43% of cows having milk with SCC greater than 250×10³ cells/ml and 600×10³ cells/ml, respectively. Infectious pathogens were also commonly isolated, with 63% of cows being positive for pathogenic bacteria. Neither intervention strategy alone had any effect on mastitis indicators or milk yield. In combination, the measures had some impact, lowering the prevalence of contagious pathogens by 18%, but this was not reflected in a significantly increased milk yield, lowered SCC or reduced incidence of clinical mastitis.     

Clinical findings in 56 cows with toxic mastitis

The clinical, haematological, biochemical and bacteriological findings in 56 cows with toxic mastitis are described. In addition to acute mastitis, the most frequent clinical findings were tachycardia in 40 of the cows, anorexia or reduced appetite in 50, reduced ruminal and intestinal motility in 52 and no ruminal and intestinal motility in 39. The most important haematological and biochemical findings were a high haematocrit in 26 of the cows, leucopenia in 23 and a high concentration of urea in 31. In 27 of the cows the secretion of the affected mammary gland did not resemble milk. The most commonly isolated bacteria were Escherichia coli from 26 of the cows and Staphylococcus aureus from 11. Seven of the cows were investigated by an exploratory laparotomy because the principal sign was intestinal in origin, but no abnormalities were found. Seventeen of the cows were euthanased immediately after the diagnostic work, and 14 during the course of their treatment.     

Effects of clinical mastitis on reproductive and milk performance of Holstein cows in Morocco

The aim of this study was to determine the influence of clinical mastitis and time of first mastitis occurrence on reproductive and milk performance of Holstein cows. Data were collected in a dairy farm from 2008 to 2012 on 1725 cows, among which 464 cows with mastitis. To determine the influence of clinical mastitis on reproductive and milk performance, models included fixed effects of parity, calving season, calving year, and group (cows with and with no mastitis). To determine the effect of time of 1st mastitis occurrence on reproductive performance, the mastitic cows group was further reclassified into three groups: prior to 60 days, between 60 and 90 days and greater than 90 days postpartum. For milk performance, the mastitic cows group was divided into two groups: before and after peak milk yield. Clinical mastitis had significant effects on calving to first AI interval, milk yield, and fat yield, but a non-significant effect on days open, number of inseminations per conception, and milk fat percentage. Mastitic cows had a calving to first AI interval 6.1 days longer and 549.6 kg milk and 20.4 kg fat per 305 days of lactation lower than those with no mastitis. Time of 1st mastitis occurrence did not have any significant effect on reproductive performance. Further, milk and fat yields of cows diseased before peak milk yield were 506 kg and 23.9 kg, respectively, lower than those of cows affected after peak milk yield. Extra attention needs to be paid to mastitis during the early postpartum period.

     

Experimental infection of lactating bovine mammary glands with Streptococcus uberis in quarters colonized by Corynebacterium bovis

Twenty-seven quarters of 18 lactating dairy cows were inoculated intramammarily with 3.6 X 10(4) colony-forming units (CFU) of a strain of Streptococcus uberis isolated from a cow with clinical mastitis. Before quarters were inoculated, 22 were considered as naturally colonized with Corynebacterium bovis, and 5 were considered bacteriologically negative. Streptococcus uberis was isolated from all quarters within 2 days after inoculation, and all quarters developed clinical mastitis by 3 days after inoculation. Mastitis was acute, and most cows had increased rectal temperatures. The number of somatic cells increased significantly (P less than 0.05), and milk production decreased significantly. In many cows, rectal temperatures remained increased, and Str uberis was isolated from infected glands after intramammary and systemic antimicrobial treatments were given. A decreased number (110 CFU) of the same strain of Str uberis caused equally severe mastitis in 3 quarters colonized with C bovis and in 1 bacteriologically negative quarter in 2 cows. Streptococcus uberis was isolated from all inoculated quarters, and all quarters developed clinical mastitis by 2 days after inoculation. Two quarters colonized with C bovis and 2 bacteriologically negative quarters were inoculated once with 25 CFU and once with 240 CFU of a different strain of Str uberis (ATCC 27958). Streptococcus uberis was never isolated from inoculated quarters, and changes in milk yield or number of somatic cells were not observed.     

BoLA-DQA、DRB3* exon2多态性及其与奶牛乳房炎的关联分析

采用PCR-SSCP技术，检测到9种中国荷斯坦牛BoLA-DQA^＊ exon2基因基因型、15种BoLA-DRB3^＊ exon2基因的基因型和3种单体型，分析比较了各基因型、单体型与奶牛乳房炎的关联性。结果在中国荷斯坦牛中，没有发现与乳房炎易感性或抗性有关联的基因和基因型，但发现DQA-B／DRB3-C、DQA-G／DRB3-F两种单体型可能与奶牛乳房炎易感性有关，而DQBF／DRB3-E单体型可能与奶牛乳房炎抗性有关。     

Genome-wide scan for selective sweeps identifies novel loci associated with resistance to mastitis in German Holstein cattle

Domestication and selection significantly changed phenotypic and behavioural traits in modern domestic animals. In this study, to identify the genomic regions associated with mastitis, genomic data of German Holstein dairy cattle were analysed. The samples were genotyped using the Bovine 50 K SNP chip. For each defined healthy and sick group, 133 samples from 13,276 genotyped dairy cows were selected based on mastitis random residual effects. Grouping was done to infer selection signatures based on XP-EHH statistic. The results revealed that for the top 0.01 percentile of the obtained XP-EHH values, five genomic regions on chromosomes 8, 11, 12, 14 and 26 of the control group, and four regions on chromosomes 3, 4 (two regions) and 22 of the case group, have been under selection. Also, consideration of the top 0.1 percentile of the XP-EHH values, clarified 21 and 15 selective sweeps in the control and case group, respectively. This study identified some genomic regions containing potential candidate genes associated with resistance and susceptibility to mastitis, immune system and inflammation, milk traits, udder morphology and different types of cancers. In addition, these regions overlap with some quantitative trait loci linked to clinical mastitis, immunoglobulin levels, somatic cell score, udder traits, milk fat and protein, milk yield, milking speed and veterinary treatments. It is noteworthy that we found two regions in the healthy group (on chromosomes 12 and 14) with strong signals, which were not described previously. It is likely that future research could link these identified genomic regions to mastitis. The results of the current study contribute to the identification of causal mutations, genomic regions and genes affecting mastitis incidence in dairy cows.     

Quarter-milking-, quarter-, udder- and lactation-level risk factors and indicators for clinical mastitis during lactation in pasture-fed dairy cows managed in an automatic milking system

Objectives To identify risk factors and indicators at quarter‐milking and other levels for clinical mastitis during lactation in pasture‐fed cows managed in an automatic milking system. Design A retrospective nested case–control study using data collected over a 31‐month period. A total of 803,948 quarter‐milkings from 249 cows were available for analysis, of which 245 were selected as clinical mastitis quarter‐milking cases and 2450 unaffected quarter‐milkings were selected as controls. Most of the diagnoses of clinical mastitis had been made after clinical assessments of quarters following automated alerts by the milking system. Potential risk factors and indicators were assessed using univariable and multivariable multilevel logistic models. Results Quarters that are milked infrequently and have low yield, fast peak milk flow rates, blood in the milk and/or elevated milk conductivity are at increased risk of clinical mastitis. Quarters were also at increased risk between days 10 and 29 of lactation, and during higher parity lactations. Milk fat and protein concentrations and the fat : protein ratio were not significantly associated with the development of clinical mastitis. Neither quarter position (fore or rear) nor side (left or right) was associated with clinical mastitis occurrence. Quarters that had been clinically affected more than 30 days previous in the current lactation were not at increased risk of redeveloping clinical mastitis. Conclusions Under the study conditions, the risk of clinical mastitis increased for quarter‐milkings in quarters that were milked less frequently in the previous 7 days, were low‐yielding, had fast peak milk flow rates and had more milkings in which blood was detected in milk and/or the milk conductivity was elevated. Risk was also increased in days 10–29 of lactation and in higher parity lactations.     

复方阿莫西林乳房注入剂对临床型奶牛乳房炎的治疗效果

为评价复方阿莫西林乳房注入剂对泌乳期奶牛临床型乳房炎的治疗效果,在甘肃某两个牛场选择70头自然发生的临床型乳房炎奶牛进行临床试验。将患病奶牛随机分为试验组(n=36头)和对照组(n=34头)。试验用药和对照用药分别为郑州百瑞动物药业有限公司和齐鲁动物保健品有限公司提供的复方阿莫西林乳房注入剂。每个感染乳区注入3 g药物,每12 h注射1次,连续用药3 d。在用药前、停药后7 d及14 d采集各组奶牛的奶样进行细菌学检测及乳汁体细胞计数。通过临床观察、细菌清除率及体细胞计数变化对临床疗效进行评价。停药后14 d,试验组和对照组的临床治愈率分别为58.3%和61.8%,细菌总清除率分别为94.12%和93.55%。两组奶样中的SCC在治疗后均显著下降(P<0.01)。两组临床疗效无统计学差异(P>0.05),表明试验用药对奶牛临床型乳房炎具有良好的治疗效果。